GLUE
Price
$5.29
Change
+$0.23 (+4.55%)
Updated
Jul 9 closing price
Capitalization
325.39M
28 days until earnings call
NRIX
Price
$13.18
Change
+$0.97 (+7.94%)
Updated
Jul 9 closing price
Capitalization
1B
Earnings call today
Interact to see
Advertisement

GLUE vs NRIX

Header iconGLUE vs NRIX Comparison
Open Charts GLUE vs NRIXBanner chart's image
Monte Rosa Therapeutics
Price$5.29
Change+$0.23 (+4.55%)
Volume$549.23K
Capitalization325.39M
Nurix Therapeutics
Price$13.18
Change+$0.97 (+7.94%)
Volume$980.17K
Capitalization1B
GLUE vs NRIX Comparison Chart in %
Loading...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLUE vs. NRIX commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a Buy and NRIX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (GLUE: $5.29 vs. NRIX: $13.18)
Brand notoriety: GLUE and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLUE: 128% vs. NRIX: 121%
Market capitalization -- GLUE: $325.39M vs. NRIX: $1B
GLUE [@Biotechnology] is valued at $325.39M. NRIX’s [@Biotechnology] market capitalization is $1B. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 1 FA rating(s) are green whileNRIX’s FA Score has 1 green FA rating(s).

  • GLUE’s FA Score: 1 green, 4 red.
  • NRIX’s FA Score: 1 green, 4 red.
According to our system of comparison, GLUE is a better buy in the long-term than NRIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 6 TA indicator(s) are bullish while NRIX’s TA Score has 5 bullish TA indicator(s).

  • GLUE’s TA Score: 6 bullish, 4 bearish.
  • NRIX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GLUE is a better buy in the short-term than NRIX.

Price Growth

GLUE (@Biotechnology) experienced а +11.84% price change this week, while NRIX (@Biotechnology) price change was +5.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +12.58%. For the same industry, the average monthly price growth was +16.60%, and the average quarterly price growth was +18.46%.

Reported Earning Dates

GLUE is expected to report earnings on Nov 06, 2025.

NRIX is expected to report earnings on Oct 09, 2025.

Industries' Descriptions

@Biotechnology (+12.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($1.01B) has a higher market cap than GLUE($325M). GLUE YTD gains are higher at: -23.775 vs. NRIX (-30.042). GLUE has higher annual earnings (EBITDA): 6.14M vs. NRIX (-214M). NRIX has more cash in the bank: 550M vs. GLUE (326M). NRIX has less debt than GLUE: NRIX (26.6M) vs GLUE (41.9M). GLUE has higher revenues than NRIX: GLUE (159M) vs NRIX (56.4M).
GLUENRIXGLUE / NRIX
Capitalization325M1.01B32%
EBITDA6.14M-214M-3%
Gain YTD-23.775-30.04279%
P/E Ratio44.08N/A-
Revenue159M56.4M282%
Total Cash326M550M59%
Total Debt41.9M26.6M158%
TECHNICAL ANALYSIS
Technical Analysis
GLUENRIX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FVSKX54.99N/A
N/A
Fidelity Value Strategies K
TRIFX4.69N/A
N/A
Catalyst/SMH Total Return Income A
TVFRX17.48N/A
N/A
NAA Allocation P
GWETX31.74N/A
N/A
AMG GW&K Small Cap Core N
FUFRX24.13N/A
N/A
Franklin Utilities R6

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been closely correlated with KYMR. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
+7.94%
KYMR - NRIX
66%
Closely correlated
+4.03%
IDYA - NRIX
59%
Loosely correlated
+7.09%
DNLI - NRIX
58%
Loosely correlated
+4.68%
BEAM - NRIX
57%
Loosely correlated
+5.71%
RNA - NRIX
56%
Loosely correlated
+6.91%
More